Probiotix HealthFRA:X90 Days Inventory is 4.88 as of Dec. 2025, which is 82% below its 10-year median of 27.60. The stock has 1 warning sign investors should review. Among 636 Biotechnology companies, Probiotix Health ranks better than 96.86% on this metric.
The historical rank and industry rank for Probiotix Health's Days Inventory or its related term are showing as below:
FRA:X90'
s Days Inventory Range Over the Past 10 Years
Min: 9.05 Med: 27.6 Max: 33.26
Current: 13.92
During the past 7 years, Probiotix Health's highest Days Inventory was 33.26. The lowest was 9.05. And the median was 27.60.
FRA:X90's Days Inventory is ranked better than 96.86% of 636
companies
in the Biotechnology industry
Industry Median: 183.195
vs FRA:X90: 13.92
Probiotix Health's Days Inventory
declined
from Dec. 2024 (25.37) to Dec. 2025 (4.88).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Probiotix Health's Inventory Turnover for the
six
months ended in Dec. 2025 was 37.40.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Probiotix Health's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.01.
Probiotix Health (FRA:X90) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Probiotix Health's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Probiotix Health's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Probiotix Health Days Inventory Related Terms
Probiotix Health Days Inventory Historical Data
* Premium members only.
The historical data trend for Probiotix Health's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:X90 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Probiotix Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Probiotix Health Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Probiotix Health's Days Inventory distribution charts can be found below:
* The bar in red indicates where Probiotix Health's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Probiotix Health (FRA:X90) has a Days Inventory of 4.88 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Probiotix Health and its competitors. This is 82% below median its historical median of 27.60. Over the past decade, Probiotix Health's Days Inventory has ranged from 9.05 to 33.26. According to the industry distribution chart, Probiotix Health ranks #20 out of 636 companies in the Biotechnology industry, placing it in the top 3.1%.
Is Probiotix Health's Days Inventory too high?
Probiotix Health's current Days Inventory of 4.88 is 82% below median its 10-year median of 27.60. Over the past 10 years, this metric has ranged from a low of 9.05 to a high of 33.26. The Biotechnology industry median Days Inventory is 183.20. Probiotix Health's value of 4.88 is 97.3% below this industry median. Based on the distribution chart, Probiotix Health ranks #20 out of 636 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Probiotix Health's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Probiotix Health ranks #20 out of 636 companies for Days Inventory. This places Probiotix Health in the top 3% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.20. Probiotix Health's value of 4.88 is 97.3% below this benchmark. Historically, Probiotix Health's own Days Inventory has ranged from 9.05 to 33.26 over the past decade. While the company's 10-year median is 27.60 vs. the industry median of 183.20, Probiotix Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 636 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Probiotix Health's current Days Inventory of 4.88 is 97.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Probiotix Health and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Probiotix Health's current Days Inventory is 4.88, which is 82% below median its own 10-year median of 27.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Probiotix Health stock overvalued right now?
Probiotix Health (FRA:X90) has a current Days Inventory of 4.88. The stock's GF Value™ is €0.10, compared to a current price of €0.07 — trading 25.5% below its estimated fair value. The current Days Inventory is 4.88, which is 82% below median its 10-year median of 27.60 and 97.3% below the Biotechnology industry median of 183.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Probiotix Health (FRA:X90), the current Days Inventory is 4.88 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:X90 has been successfully added to your 